Drug Trial Radar · NCT01945775
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
Last checked: Nov 19, 2026Latest source record: Jan 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
431
Actual
Start
Oct 14, 2013
Primary completion
Sep 15, 2017
Study completion Mar 5, 2021
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- Medivation, Inc.
- First posted
- Sep 19, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this open-label, 2:1 randomized phase III trial is to compare the safety and efficacy of talazoparib (also known as BMN 673) versus protocol-specific physician's choice in patients who have locally advanced and/or metastatic breast cancer with germline BRCA mutations.
Conditions
- Breast Neoplasms
- BRCA 1 Gene Mutation
- BRCA 2 Gene Mutation
Interventions
talazoparibDrug
Until progression or unacceptable toxicity develops
Physician's-ChoiceDrug
Capecitabine, Eribulin, Gemcitabine or Vinorelbine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS): Independent Radiological Facility (IRF) AssessmentTime frame: Baseline until radiologic progressive disease or death due to any cause (up to maximum duration of 36.9 months)
Locations
362 sites in 16 countries. Site status is shown where the registry gives one.
Arizona Oncology Associates P.C. - NAHOA
Flagstaff, Arizona
HonorHealth
Scottsdale, Arizona
Virginia G. Piper Cancer Pharmacy
Scottsdale, Arizona
Kaiser Permanente Medical Center Lab Drawing Station
Antioch, California
Kaiser Permanente Medical Center Lab Drawing Station
Antioch, California
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center
Bakersfield, California
Kaiser Permanente Medical Center Lab Drawing Station
Fairfield, California
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare
Fullerton, California
Kaiser Permanente Medical Center Lab Drawing Station
Gilroy, California
Los Angeles Hematology Oncology Medical Group
Glendale, California
Los Angeles Hematology Oncology Medical Group
Glendale, California
Marin Specialty Care
Greenbrae, California
Los Angeles Hematology Oncolgy Medical Group
Los Angeles, California
Los Angeles Hematology Oncology Medical Group
Los Angeles, California
Drug Management Only: UCLA West Medical Pharmacy, Attn:Steven L. Wong, Pharm.D.
Los Angeles, California
Drug Management only: UCLA West Medical Pharmacy
Los Angeles, California
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm. D.
Los Angeles, California
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D.
Los Angeles, California
UCLA West Medical Pharmacy, Attn: Steven L. Wong
Los Angeles, California
UCLA West Medical Pharmacy, Attn:Steven L. Wong, Pharm.D.
Los Angeles, California
Regulatory Managment Only: TRIO-US Central Administration
Los Angeles, California
Ronald Reagan UCLA Medical Center
Los Angeles, California
TRIO-US Central Administration
Los Angeles, California
UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D.
Los Angeles, California
University of California Los Angeles
Los Angeles, California
Kaiser Permanente Medical Center Lab Drawing Station
Martinez, California
Kaiser Permanente Medical Center Lab Drawing Station
Milpitas, California
Kaiser Permanente Medical Center Lab Drawing Station
Modesto, California
Kaiser Permanente Medical Center Lab Drawing Station
Mountain View, California
Kaiser Permanente Medical Center Lab Drawing Station
Napa, California
Kaiser Permanente Medical Center (clinic+DSL)
Oakland, California
Kaiser Permanente Medical Center (Radiology)
Oakland, California
Kaiser Permanente Medical Center Lab Drawing Station
Pleasanton, California
Torrance Health Association, DBA Torrance Memorial Physician Network/Cancer care Associates
Redondo Beach, California
Kaiser Permanente Medical Center Lab Drawing Station
Redwood City, California
Kaiser Permanente Medical Center (clinic+DSL)
Roseville, California
Southern California Permanente Medical Group
San Diego, California
UCSF - Helen Diller Family Comprehensive Cancer Center
San Francisco, California
UCSF Helen Diller Comprehensive Cancer Centre - Precision Cancer Medicine Building
San Francisco, California
Kaiser Permanente Mission Bay Medical Center Lab Drawing Station
San Francisco, California
Showing 40 of 362 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.